Bacterial risk factors for treatment failure and relapse among patients with isoniazid resistant tuberculosis
Background Drug resistant tuberculosis (TB) is increasing in prevalence worldwide.
Treatment failure and relapse is known to be high for patients with isoniazid resistant TB
treated with standard first line regimens. However, risk factors for unfavourable outcomes
and the optimal treatment regimen for isoniazid resistant TB are unknown. This cohort study
was conducted when Vietnam used the eight month first line treatment regimen and
examined risk factors for failure/relapse among patients with isoniazid resistant TB. Methods …
Treatment failure and relapse is known to be high for patients with isoniazid resistant TB
treated with standard first line regimens. However, risk factors for unfavourable outcomes
and the optimal treatment regimen for isoniazid resistant TB are unknown. This cohort study
was conducted when Vietnam used the eight month first line treatment regimen and
examined risk factors for failure/relapse among patients with isoniazid resistant TB. Methods …
Bacterial risk factors for treatment failure and relapse among patients with isoniazid resistant tuberculosis.
PVKT Phan Vuong Khac Thai… - 2018 - cabidigitallibrary.org
Background: Drug resistant tuberculosis (TB) is increasing in prevalence worldwide.
Treatment failure and relapse is known to be high for patients with isoniazid resistant TB
treated with standard first line regimens. However, risk factors for unfavourable outcomes
and the optimal treatment regimen for isoniazid resistant TB are unknown. This cohort study
was conducted when Vietnam used the eight month first line treatment regimen and
examined risk factors for failure/relapse among patients with isoniazid resistant TB. Methods …
Treatment failure and relapse is known to be high for patients with isoniazid resistant TB
treated with standard first line regimens. However, risk factors for unfavourable outcomes
and the optimal treatment regimen for isoniazid resistant TB are unknown. This cohort study
was conducted when Vietnam used the eight month first line treatment regimen and
examined risk factors for failure/relapse among patients with isoniazid resistant TB. Methods …
以上显示的是最相近的搜索结果。 查看全部搜索结果